Investing Profile

Johannes Fruehauf

InvestorVC
GENERAL PARTNER at Mission BioCapital
missionbiocapital.comCambridge, Massachusetts
Photo of Johannes Fruehauf, General Partner at Mission BioCapital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Mission BioCapital General Partner
$100K - $5.0M
$1.5M
6
$275M
CompanyStageDateRound SizeTotal Raised
Zag Bio
Series AOct 2025$80M
$80M
Co-investors: Alan Crane (Polaris Partners)
QurAlis
Series BMar 2023$88M
Series AMay 2020$42M
SeedNov 2018$6M
$140M
Co-investors: Amy Schulman (Polaris Partners), Philip Scheltens (EQT Life Sciences), Cillian King (EQT Life Sciences), Roel Bulthuis (INKEF Capital), Jeffrey Moore (MP Healthcare Venture Management), Stephen Thompson (Brandon Capital Partners), Laia Crespo (Sanofi Ventures)
Sentien Biotechnologies
Series AApr 2017$12M
$12M
Co-investors: Martin Heidecker (AMR Action Fund)
Sentieon
Series AApr 2014$4M
$4M
Co-investors: Martin Heidecker (AMR Action Fund)